Design Strategies for Hyaluronic Acid-based Drug Delivery Systems in Cancer Immunotherapy.

Area of Science:

• Biomedical Engineering
• Immunology
• Materials Science

Background:

• Cancer immunotherapy faces challenges with refractory tumors, limiting survival rates.
• Advanced drug delivery systems can improve immunotherapy but have modest impact.
• Hyaluronic acid, a common drug delivery polymer, has emerging links to immune system modulation.

Purpose of the Study:

• To review the immunological properties of hyaluronic acid.
• To discuss its bioactive functions and interactions with cellular components.
• To analyze its potential in advanced drug delivery for cancer immunotherapy.

Main Methods:

• Literature review of hyaluronic acid's immunological properties.
• Analysis of hyaluronic acid's interactions with immune and cancer cells.
• Exploration of hyaluronic acid in drug delivery systems for cancer therapy.

Main Results:

• Hyaluronic acid exhibits immunomodulatory functions relevant to cancer therapy.
• Its interactions with cellular receptors and components are key to its immune effects.
• Strategies exist to incorporate hyaluronic acid into advanced drug delivery systems.

Conclusions:

• Hyaluronic acid holds significant potential for next-generation cancer immunotherapies.
• Further research and clinical translation are needed to maximize its therapeutic benefits.
• Designing effective hyaluronic acid-based drug delivery systems can overcome current immunotherapy limitations.